Literature DB >> 27693494

Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.

Yijie Chen1, Yang Yu1, Shuya Sun1, Zhaotong Wang2, Peiqing Liu3, Shenglan Liu1, Jianmin Jiang4.   

Abstract

Tumor metastasis is the main reason of death for hepatocellular carcinoma (HCC) patients. Cell migration and invasion are two prerequisites for tumor metastasis, in which TRPM7 and MMPs play an important role. In our study, we found that bradykinin (BK) could upregulate the expression of TRPM7 and dynamically regulate the phosphorylation of non-muscle myosin IIA heavy chain (NMHC-IIA) Ser-1943 in HepG2 cells. The influx of Ca2+ via TRPM7 was necessary for elevating the activity of m-calpain and μ-calpain. Additionally, we observed that BK stimulated HepG2 cells to secrete more MMP2 but not MMP9. Src was critical in the process of MMP2 secretion and invadopodia formation. The heat map showed that BDKRB2, TRPM7 and MMP2 had higher overexpression proportions in 25 HCC cell lines. Some clinical specimens of HCC also indicated that BDKRB2 and MMP2 were overexpressed. In conclusion, BK promoted migration and invasion of HCC cells through TRPM7 and MMP2.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Bradykinin; Invasion; MMP2; Migration; TRPM7

Mesh:

Substances:

Year:  2016        PMID: 27693494     DOI: 10.1016/j.yexcr.2016.09.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

Review 1.  Mammalian nonmuscle myosin II comes in three flavors.

Authors:  Maria S Shutova; Tatyana M Svitkina
Journal:  Biochem Biophys Res Commun       Date:  2018-03-17       Impact factor: 3.575

2.  CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.

Authors:  Tingting Ren; Lili Zhu; Mingliang Cheng
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

3.  TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.

Authors:  Yuyang Sun; Anne Schaar; Pramod Sukumaran; Archana Dhasarathy; Brij B Singh
Journal:  Mol Carcinog       Date:  2018-03-15       Impact factor: 4.784

4.  The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.

Authors:  Mengyuan Lyu; Jian Zhou; Hao Chen; Hao Bai; Jiajia Song; Tangyuheng Liu; Yuhui Cheng; Binwu Ying
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.889

5.  BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma.

Authors:  Ying Yang; Jin Wang; Fei Shi; Aijun Shan; Shihai Xu; Wen Lv
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

6.  Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.

Authors:  Fei Xu; Qianqian Tang; Yejinpeng Wang; Gang Wang; Kaiyu Qian; Lingao Ju; Yu Xiao
Journal:  Front Genet       Date:  2021-12-06       Impact factor: 4.599

7.  ZNF259 inhibits non-small cell lung cancer cells proliferation and invasion by FAK-AKT signaling.

Authors:  Yuemei Shan; Wei Cao; Tao Wang; Guiyang Jiang; Yong Zhang; Xianghong Yang
Journal:  Cancer Manag Res       Date:  2017-12-14       Impact factor: 3.989

8.  Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.

Authors:  Ying Zhou; Wei Wang; Rui Wei; Guiying Jiang; Fei Li; Xi Chen; Xueqian Wang; Sixiang Long; Ding Ma; Ling Xi
Journal:  Int J Oncol       Date:  2019-05-02       Impact factor: 5.650

9.  The Bradykinin-BDKRB1 Axis Regulates Aquaporin 4 Gene Expression and Consequential Migration and Invasion of Malignant Glioblastoma Cells via a Ca2+-MEK1-ERK1/2-NF-κB Mechanism.

Authors:  Ding-Ping Sun; Yuan-Wen Lee; Jui-Tai Chen; Yung-Wei Lin; Ruei-Ming Chen
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

Review 10.  TRP Channels in Digestive Tract Cancers.

Authors:  Paulina Stokłosa; Anna Borgström; Sven Kappel; Christine Peinelt
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.